Edwards Lifesciences Corp (EW)
Who owns Edwards Lifesciences Corp (EW)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.7% of the shares are freely tradable; institutional investors hold 94.1%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 12.17 | 70,079,435 | -0.4 | 12/31/2025 |
| BlackRock Inc | 9.13 | 52,590,933 | +0.2 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.55 | 37,727,792 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.59 | 26,407,018 | +0.0 | 03/31/2026 |
| State Street Corp | 4.57 | 26,296,399 | +1.2 | 03/31/2026 |
| Wellington Management Company LLP | 3.82 | 22,011,101 | +1.0 | 03/31/2026 |
| JPMorgan Chase & Co | 3.78 | 21,744,712 | -16.4 | 03/31/2026 |
| Bank of New York Mellon Corp | 2.91 | 16,737,548 | -4.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.21 | 18,501,863 | +0.3 | 04/30/2026 |
| Vanguard 500 Index Investor | 2.61 | 15,045,795 | +1.8 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 30. Jul 2026 | Markowitz Wayne | CVP, JAPAC | Sell | 146 | 86.03 | 12,561 |
| 28. Jul 2026 | Markowitz Wayne | CVP, JAPAC | Sell | 9,628 | 85.06 | 818,958 |
| 28. Jul 2026 | Markowitz Wayne | CVP, JAPAC | Other | 9,628 | 74.02 | 712,665 |
| 27. Jul 2026 | Zovighian Bernard J | CEO | Sell | 2,921 | 83.93 | 245,172 |
| 27. Jul 2026 | Zovighian Bernard J | CEO | Other | 320 | 0.00 | – |
| 11. Jul 2026 | Bruls Annette | CVP, EMEACLA | Other | 109 | 92.21 | 10,051 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.